Fresenius Medical Care AG & Co. KGaA (ETR:FME) Receives €42.00 Price Target at Warburg Research

0

Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) was given a target price of €42.00 ($43.30) by equity research analysts Warburg Research in a report on Friday, Borsen Zeitung reports. Warburg Research’s target price would indicate a potential upside of 13.79% from the current stock price.

A number of other research companies also commented on FME. Berenberg Bank set a price target of €76.70 ($79.07) on shares of Fresenius Medical Care AG & Co. KGaA in a Wednesday, July 27 research report. UBS Group set a target price of €38.00 ($39.18) on shares of Fresenius Medical Care AG & Co. KGaA in a Friday, July 29 research report. Deutsche Bank Aktiengesellschaft set a target price of €37.00 ($38.14) on shares of Fresenius Medical Care AG & Co. KGaA in a Tuesday, August 2 research report. set a target price of €58.00 ($59.79) on shares of Fresenius Medical Care AG & Co. KGaA in a Friday, July 29 research report. Finally, Jefferies Financial Group set a price target of €64.00 ($65.98) on shares of Fresenius Medical Care AG & Co. KGaA in a Monday, July 25 report.

Fresenius Medical Care AG & Co. KGaA share performance

ETR FME opened at €36.91 ($38.05) on Friday. Fresenius Medical Care AG & Co. KGaA has a 52-week minimum of €35.08 ($36.16) and a 52-week maximum of €69.96 ($72.12). The company has a 50-day simple moving average of €47.24 and a 200-day simple moving average of €55.00. The company has a debt ratio of 88.41, a quick ratio of 0.70 and a current ratio of 1.18. The company has a market capitalization of $10.83 billion and a PE ratio of 13.18.

Fresenius Medical Care AG & Co. KGaA Company Profile

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Featured articles



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.